We are live on
!
Find out more
CM
Castleark Management Portfolio holdings
AUM
$3.02B
1-Year Est. Return
53.92%
This Fund
S&P 500
This Quarter
Est. Return
-15.33%
1 Year Est. Return
+53.92%
3 Year Est. Return
+208.37%
5 Year Est. Return
+342.22%
10 Year Est. Return
+3,246.09%
AUM
$1.87B
AUM Growth
-$449M
(-19%)
Cap. Flow
-$58.7M
Cap. Flow
% of AUM
-3.14%
Top 10 Holdings %
Top 10 Hldgs %
33.16%
Holding
358
New
37
Increased
55
Reduced
86
Closed
52
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$48.3M |
| 2 |
UnitedHealth
UNH
|
+$32.7M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$19.2M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$17.8M |
| 5 |
CME Group
CME
|
+$15.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microchip Technology
MCHP
|
+$39.5M |
| 2 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$26.5M |
| 3 |
Freeport-McMoran
FCX
|
+$17.7M |
| 4 |
MRO
Marathon Oil Corporation
MRO
|
+$17.1M |
| 5 |
Regal Rexnord
RRX
|
+$12.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.33% |
| 2 | Healthcare | 15.76% |
| 3 | Consumer Discretionary | 13.02% |
| 4 | Financials | 12.7% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Western Midstream Partners
WES
$19.4B
| $5.66M | 0.3% |
232,770
| – | – |
|
77
Helen of Troy
HELE
$653M
| $5.58M | 0.3% |
34,360
+8,050
| +31% | +$1.52M |
|
78
Magnolia Oil & Gas
MGY
$5.92B
| $5.56M | 0.3% |
264,850
-7,210
| -3% | -$180K |
|
|
AXNX
79
DELISTED
Axonics, Inc. Common Stock
AXNX
| $5.56M | 0.3% |
98,050
+13,092
| +15% | +$718K |
|
80
Alkermes
ALKS
$8.09B
| $5.46M | 0.29% |
+183,340
| New | +$5.27M |
|
81
EastGroup Properties
EGP
$11.2B
| $5.44M | 0.29% |
35,270
-7,910
| -18% | -$1.39M |
|
82
MPLX
MPLX
$58.6B
| $5.44M | 0.29% |
186,662
| – | – |
|
83
iShares MSCI Emerging Markets ETF
EEM
$27.4B
| $5.43M | 0.29% |
135,300
| – | – |
|
84
Haemonetics
HAE
$3.89B
| $5.41M | 0.29% |
+83,050
| New | +$4.92M |
|
85
Rapid7
RPD
$627M
| $5.38M | 0.29% |
80,585
+20,630
| +34% | +$1.7M |
|
86
Performance Food Group
PFGC
$18.3B
| $5.37M | 0.29% |
116,680
+2,640
| +2% | +$122K |
|
87
Dycom Industries
DY
$11.2B
| $5.28M | 0.28% |
56,750
+4,290
| +8% | +$382K |
|
88
Wells Fargo
WFC
$254B
| $5.28M | 0.28% |
134,700
| – | – |
|
89
Neurocrine Biosciences
NBIX
$18.2B
| $5.26M | 0.28% |
54,000
+8,760
| +19% | +$808K |
|
90
Matador Resources
MTDR
$6.07B
| $5.26M | 0.28% |
112,880
-63,620
| -36% | -$3.45M |
|
91
Huntington Bancshares
HBAN
$34B
| $5.24M | 0.28% |
435,700
| – | – |
|
|
NUVA
92
DELISTED
NuVasive, Inc.
NUVA
| $5.23M | 0.28% |
106,460
+8,610
| +9% | +$462K |
|
|
EVRI
93
DELISTED
Everi Holdings
EVRI
| $5.17M | 0.28% |
316,939
-79,109
| -20% | -$1.39M |
|
|
ITCI
94
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $5.15M | 0.28% |
90,180
+49,910
| +124% | +$2.83M |
|
95
Lumentum
LITE
$46.8B
| $5.11M | 0.27% |
64,300
-2,950
| -4% | -$252K |
|
|
ATSG
96
DELISTED
Air Transport Services Group
ATSG
| $5.1M | 0.27% |
177,640
+43,790
| +33% | +$1.33M |
|
97
KeyCorp
KEY
$23.8B
| $5.09M | 0.27% |
295,300
| – | – |
|
98
Agree Realty
ADC
$9.65B
| $4.98M | 0.27% |
+69,100
| New | +$4.8M |
|
99
Caesars Entertainment
CZR
$6.06B
| $4.98M | 0.27% |
129,950
+790
| +0.6% | +$44K |
|
100
Advanced Drainage Systems
WMS
$10.6B
| $4.97M | 0.27% |
55,150
-25,100
| -31% | -$2.58M |
|
Similar funds
MCM
JIC
CFM
SM
TAM
KIA
BGDI
Castleark Management's Q2 2022 Portfolio in Review
As of Q2 2022, Castleark Management held 358 positions worth $1.87B, down 19% from $2.32B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Castleark Management withdrew a net $58.7M in Q2 2022, closing 52 positions and reducing 86 holdings. Its most notable exit was State Street Materials Select Sector SPDR ETF, an estimated $26.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Castleark Management opened a new position in State Street SPDR S&P Biotech ETF worth $47.8M.
- Castleark Management's largest Q2 2022 buy was State Street SPDR S&P Biotech ETF: 643,890 shares worth $47.8M.
- Castleark Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $17.8M increase.
- Castleark Management's biggest Q2 2022 reduction was Microchip Technology, cutting an estimated $39.5M.
- Castleark Management fully exited State Street Materials Select Sector SPDR ETF in Q2 2022, selling an estimated $26.5M.
- Castleark Management's ten largest holdings make up 33% of its $1.87B portfolio in Q2 2022.
- Castleark Management opened 37 new positions and closed 52 in Q2 2022.
- Castleark Management's portfolio value fell 19% quarter-over-quarter to $1.87B.
Based on Castleark Management's 13F filing for Q2 2022, filed 16 Aug 2022.